Back to Trades
Schwartz Alexander Duke
Chief Financial OfficerCIK 0002145254
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 1
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Schwartz Alexander Duke, Chief Financial Officer, has filed 1 SEC report (2026), all concentrated in Retension Pharmaceuticals, Inc. (RTSN), totaling $0 in disclosed volume. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
1 loaded
| Oct 8 | RTSN Retension Pharmaceuticals, Inc. | Schwartz Alexander Duke | Chief Financial Officer | Other | $0 |
1 filing